Merck Total Liabilities 2010-2024 | MRK

Merck total liabilities for the quarter ending June 30, 2024 were $68.982B, a 4.95% increase year-over-year.

  • Merck total liabilities for 2023 were $69.04B, a 9.41% increase from 2022.
  • Merck total liabilities for 2022 were $63.102B, a 6.43% decline from 2021.
  • Merck total liabilities for 2021 were $67.437B, a 1.89% increase from 2020.

Merck Total Liabilities 2010-2024 | MRK

  • Merck total liabilities for 2023 were $69.04B, a 9.41% increase from 2022.
  • Merck total liabilities for 2022 were $63.102B, a 6.43% decline from 2021.
  • Merck total liabilities for 2021 were $67.437B, a 1.89% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B